The Federal law No. 127-FZ “On measures (countermeasures) in response to the hostile acts of the USA and other foreign countries” (“the Law”) has come into effect on June 04, 2018.

On 24 April 2018 the Intellectual Property Court published its Decision in case A41 85807/2016 between Swiss-based Novartis AG and local generic Nativa LLC.

Lidings’ partner, head of the bankruptcy and restructuring practice at Lidings Stepan Guzey will take part in conference dedicated to the bankruptcy issues in Russia organized by Pravo.ru.

At present, the direction of medicine, such as telemedicine, becomes more and more known and the number of questions about the procedure of providing medical assistance using telemedicine is also growing.

On March 21, 2018, the Russian Supreme Court published its Decision in case No. A55 5711/2014, which may have a dramatic impact on resolution of trademark non-use disputes.

On 1 June 2018 comes into force the federal law (the “Law 212-FZ”) which allows the parties to execute escrow agreements under Russian law.

Lidings’ Bankruptcy and Restructuring practice Partner Alexander Popelyuk will run a webinar on the Specifics of Conducting Cross-Border Insolvencies.

Associate of the Lidings’ Intellectual Property practice Anastasia Skovpen will take part in a seminar entitled Trade Marks: Registration and Protection Strategy, including on the Internet organized jointly by Statut Law School and IP CLUB. The event will take place on 5-6 of June 2018 at the Russian Presidential Academy of National Economy and Public Administration (RANEPA).

On April 24th 2018 Lidings has conducted its traditional Spring Legal Brunch for its clients and partners. The meeting devoted to the Intellectual Property Protection took place at Lotte hotel in Moscow and gathered over 35 attendees — representatives of large Russian and international companies.

The Ministry of Healthcare of the Russian Federation (the “Minzdrav”) has developed draft law aimed to improve regulation of drugs circulation, namely in respect of the determination of drugs interchangeability (the "Draft Law“).